221 related articles for article (PubMed ID: 32253799)
1. Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
Schwartz RA; Janniger CK
Dermatol Ther; 2020 May; 33(3):e13380. PubMed ID: 32253799
[TBL] [Abstract][Full Text] [Related]
2. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
[TBL] [Abstract][Full Text] [Related]
3. Generalized Pustular Figurate Erythema in Patients with COVID-19 Treated with Hydroxychloroquine: A Systematic Review.
Al Muqarrab F; Schwartz RA; Almohssen AA
Acta Dermatovenerol Croat; 2022 Dec; 30(4):227-236. PubMed ID: 36919389
[TBL] [Abstract][Full Text] [Related]
4. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
Delaleu J; Deniau B; Battistella M; de Masson A; Bensaid B; Jachiet M; Lazaridou I; Bagot M; Bouaziz JD;
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2777-2779.e1. PubMed ID: 32525093
[No Abstract] [Full Text] [Related]
5. A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
Torres-Navarro I; Abril-Pérez C; Roca-Ginés J; Sánchez-Arráez J; Botella-Estrada R
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e537-e539. PubMed ID: 32455478
[No Abstract] [Full Text] [Related]
6. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Litaiem N; Hajlaoui K; Karray M; Slouma M; Zeglaoui F
Dermatol Ther; 2020 Jul; 33(4):e13565. PubMed ID: 32401410
[No Abstract] [Full Text] [Related]
7. Facts, not Fear: Safety of Hydroxychloroquine.
Kuraitis D; Murina A
Am J Med Sci; 2020 Aug; 360(2):199-200. PubMed ID: 32560964
[No Abstract] [Full Text] [Related]
8. Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine.
Haraszti S; Sendil S; Jensen N
Am J Case Rep; 2020 Oct; 21():e926901. PubMed ID: 33097683
[TBL] [Abstract][Full Text] [Related]
9. Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).
Robustelli Test E; Vezzoli P; Carugno A; Raponi F; Gianatti A; Rongioletti F; Sena P
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e457-e459. PubMed ID: 32386448
[No Abstract] [Full Text] [Related]
10. Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
Pezzarossa E; Ungari M; Caresana G; Sagradi F; Cimardi L; Pan A; Testa S; Aguggini S; Varotti E; Tanzi G; Manotti L; Ferrero G; Gusolfino MD; Trombatore M;
Am J Dermatopathol; 2021 May; 43(5):342-348. PubMed ID: 33405402
[TBL] [Abstract][Full Text] [Related]
11. Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.
Grandolfo M; Romita P; Bonamonte D; Cazzato G; Hansel K; Stingeni L; Conforti C; Giuffrida R; Foti C
Dermatol Ther; 2020 Jul; 33(4):e13499. PubMed ID: 32362051
[No Abstract] [Full Text] [Related]
12. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.
Duman H; Topal IO; Kocaturk E; Cure K; Mansuroglu I
An Bras Dermatol; 2017; 92(3):404-406. PubMed ID: 29186260
[TBL] [Abstract][Full Text] [Related]
13. The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
Liccioli G; Marrani E; Giani T; Simonini G; Barni S; Mori F
Pharmacology; 2019; 104(1-2):57-59. PubMed ID: 31067554
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.
Castner NB; Harris JC; Motaparthi K
Dermatol Ther; 2018 Sep; 31(5):e12660. PubMed ID: 30152569
[TBL] [Abstract][Full Text] [Related]
15. Comment on "Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine": Report of a COVID-19 patient with particular findings.
Suarez-Valle A; Fernandez-Nieto D; Melian-Olivera A; Dominguez-Santas M; Diaz-Guimaraens B; Garcia Del Real CM; Jimenez-Cauhe J
Dermatol Ther; 2020 Nov; 33(6):e13852. PubMed ID: 32543708
[No Abstract] [Full Text] [Related]
16. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
[TBL] [Abstract][Full Text] [Related]
17. Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis.
Pearson KC; Morrell DS; Runge SR; Jolly P
Cutis; 2016 Mar; 97(3):212-6. PubMed ID: 27023083
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
Charfi O; Kastalli S; Sahnoun R; Lakhoua G
Indian J Pharmacol; 2015; 47(6):693-4. PubMed ID: 26729969
[TBL] [Abstract][Full Text] [Related]
19. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
20. Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
Enos T; Jeong HS; Vandergriff T; Jacobe HT; Chong BF
Dermatol Ther; 2020 Nov; 33(6):e13834. PubMed ID: 32542893
[No Abstract] [Full Text] [Related]
[Next] [New Search]
